CIBC Private Wealth Group
EW icon

CIBC Private Wealth Group’s Edwards Lifesciences EW Stock Holding History

CIBC Private Wealth Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.6M Sell
89,119
-6,422
-7% -$527K 0.01% 378
2025
Q3 		$7.43M Sell
95,541
-6,883
-7% -$538K 0.01% 380
2025
Q2 		$8.01M Sell
102,424
-7,599
-7% -$567K 0.01% 367
2025
Q1 		$7.38M Sell
110,023
-116,149
-51% -$8.31M 0.02% 356
2024
Q4 		$16.8M Sell
226,172
-2,302,841
-91% -$161M 0.03% 290
2024
Q3 		$167M Sell
2,529,013
-281,732
-10% -$20.5M 0.3% 88
2024
Q2 		$258M Sell
2,810,745
-22,165
-0.8% -$1.96M 0.48% 57
2024
Q1 		$267M Sell
2,832,910
-613,848
-18% -$51.6M 0.52% 55
2023
Q4 		$263M Buy
3,446,758
+2,286,119
+197% +$159M 0.56% 51
2023
Q3 		$80.4M Sell
1,160,639
-39,976
-3% -$3.21M 0.19% 115
2023
Q2 		$113M Buy
1,200,615
+65,489
+6% +$5.69M 0.25% 99
2023
Q1 		$87.9M Sell
1,135,126
-28,630
-2% -$2.25M 0.19% 111
2022
Q4 		$18.5M Sell
1,163,756
-752,691
-39% -$58M 0.06% 198
2022
Q3 		$158M Sell
1,916,447
-58,671
-3% -$5.65M 0.43% 68
2022
Q2 		$188M Sell
1,975,118
-297,625
-13% -$30.8M 0.49% 59
2022
Q1 		$268M Buy
2,272,743
+243,299
+12% +$27.3M 0.58% 51
2021
Q4 		$263M Buy
2,029,444
+10,603
+0.5% +$1.24M 0.55% 54
2021
Q3 		$229M Buy
2,018,841
+234,170
+13% +$26.7M 0.53% 58
2021
Q2 		$185M Sell
1,784,671
-24,664
-1% -$2.32M 0.42% 66
2021
Q1 		$151M Sell
1,809,335
-268,647
-13% -$22.7M 0.38% 68
2020
Q4 		$190M Buy
2,077,982
+1,406
+0.1% +$117K 0.5% 56
2020
Q3 		$166M Buy
2,076,576
+1,660,534
+399% +$130M 0.51% 55
2020
Q2 		$28.8M Sell
416,042
-1,686,712
-80% -$120M 0.14% 109
2020
Q1 		$132M Sell
2,102,754
-47,574
-2% -$3.43M 0.57% 51
2019
Q4 		$167M Sell
2,150,328
-21,129
-1% -$1.65M 0.55% 53
2019
Q3 		$159M Sell
2,171,457
-34,173
-2% -$2.4M 0.56% 53
2019
Q2 		$136M Sell
2,205,630
-70,671
-3% -$4.27M 0.48% 62
2019
Q1 		$145M Sell
2,276,301
-63,366
-3% -$3.62M 0.56% 53
2018
Q4 		$119M Sell
2,339,667
-152,781
-6% -$7.73M 0.53% 54
2018
Q3 		$145M Sell
2,492,448
-494,895
-17% -$24.2M 0.55% 52
2018
Q2 		$145M Buy
2,987,343
+199,632
+7% +$9.32M 0.59% 48
2018
Q1 		$130M Buy
2,787,711
+41,598
+2% +$1.81M 0.56% 49
2017
Q4 		$103M Buy
2,746,113
+1,146
+0% +$42.1K 0.44% 67
2017
Q3 		$100M Buy
2,744,967
+2,416,110
+735% +$92.1M 0.46% 65
2017
Q2 		$13M Buy
328,857
+54,888
+20% +$2M 0.08% 183
2017
Q1 		$8.59M Sell
273,969
-14,916
-5% -$467K 0.05% 235
2016
Q4 		$9.02M Buy
288,885
+15,969
+6% +$517K 0.06% 225
2016
Q3 		$11M Buy
272,916
+972
+0.4% +$36.6K 0.08% 198
2016
Q2 		$9.04M Buy
271,944
+3,873
+1% +$133K 0.07% 212
2016
Q1 		$7.88M Buy
+268,071
New +$7.4M 0.06% 220

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group's EW Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Edwards Lifesciences (EW) stake by 6.7% in Q4 2025, selling an estimated $527K and leaving 89,119 shares worth $7.6M. The position accounts for 0.01% of the portfolio, ranked #378.

CIBC Private Wealth Group first reported a position in EW in Q1 2016 and has held it in 40 quarters since. The position peaked at $268M in Q1 2022. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

  • CIBC Private Wealth Group held 89,119 shares of Edwards Lifesciences worth $7.6M as of Q4 2025.
  • CIBC Private Wealth Group sold 6,422 Edwards Lifesciences shares in Q4 2025, an estimated $527K.
  • Edwards Lifesciences made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #378 holding.
  • CIBC Private Wealth Group first reported a position in Edwards Lifesciences in Q1 2016 and has held it in 40 quarters since.
  • CIBC Private Wealth Group's Edwards Lifesciences position peaked at $268M in Q1 2022.
  • 1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.